Skip to main content

Table 1 Characteristics of patients based on HOMA-IR above or below the 75th percentile

From: HOMA-IR is associated with significant angiographic coronary artery disease in non-diabetic, non-obese individuals: a cross-sectional study

 

HOMA > p75

HOMA < p75

p

N

14

40

 

Age (years)

57.78 ± 5.16

58.37 ± 7.29

0.78

Men (%)

50

40

0.51

BMI (kg/m2)

29.59 ± 5.23

25.94 ± 4.05

0.0096

AC (cm)

101.69 ± 10.47

90.67 ± 10.36

0.0016

Systolic BP (mmHg)

134.57 ± 22.49

136.25 ± 20.17

0.79

Diastolic BP (mmHg)

78.00 ± 10.65

78.77 ± 13.77

0.96

Serum creatinine (mg/dL)

0.76 ± 0.26

0.75 ± 0.18

0.90

Fasting glucose (mg/dL)

97.35 ± 5.10

91.35 ± 9.22

0.02

2 h OGTT glucose (mg/dL)

127.50 ± 36.54

126.30 ± 26.59

0.89

Fasting insulin

21.07 ± 2.65

8.71 ± 3.37

0.001

2 h OGTT insulin (mUI/L)

180.13 ± 102.06

87.59 ± 58.52

0.002

HOMA-IR

5.06 ± 0.71

1.97 ± 0.81

0.0001

HbA1c (%)

5.67 ± 0.25

5.65 ± 0.35

0.84

Total cholesterol (mg/dL)

190.21 ± 48.01

177.98 ± 48.55

0.42

HDLc (mg/dL)

42.36 ± 11.26

45.82 ± 10.89

0.31

Triglicerides (mg/dL)

168.14 ± 111.35

122.32 ± 76.55

0.094

US CRP (mg/dL)

3.60 ± 3.56

5.36 ± 6.21

0.52

Urinary albumin/creatinine (mg/g)

28.392 ± 41.58

25.93 ± 40.61

0.63

Hypertension (%)

78.5

82.0

0.77

Previous MI (%)

21.4

13.1

0.46

Smokers (%)

21.4

33.3

0.51

Statin use (%)

84.6

63.1

0.15

ACEI (%)

38.4

23.7

0.30

β-blocker (%)

69.2

57.8

0.46

ASA (%)

69.2

60.0

0.57

Nitrates (%)

23.0

15.8

0.56

  1. AC abdominal circumpherence, BMI body mass index, OGTT oral glucose tolerance test, ASA acetyl salicilic acid, US-CRP ultra sensitive C-reactive protein, ACEI angiotensin conversion enzyme inhibitor